Gaudium IVF is set to launch its IPO but governance experts are flagging intra-group financial transactions and tax investigations. A promoter’s substantial share sale and high professional fees raise questions, with concerns about promoter revenue streams and compliance.
Recent Posts
- US Stocks | US stocks end lower, post weekly loss as war on Iran fuels inflation worries
- Nifty down 2%: Deepak Gupta’s sector-by-sector playbook for what to buy, hold, and trim
- Bitcoin can survive 72% of the world’s submarine cables being cut, but a targeted attack on five hosting providers could cripple it
- AI Push Could Trigger 20% Cut In Meta’s Workforce, Biggest Since 2023, Says Report
- US-Iran War Live Updates: US Kicks Off Oil Reserve Release; Orders Partial Evacuation Of Oman Staff